PET/CT imaging of bone disorders in dysparathyroidism: a comprehensive review
Authors:
Open Access
- 23 October 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Nuclear Medicine
- Vol. 5, 1645497
Abstract
Parathyroid disorders profoundly affect bone metabolism, often long before structural damage is apparent on conventional imaging. Positron emission tomography/computed tomography (PET/CT) has emerged as a transformative tool in dysparathyroidism, enabling visualization of early metabolic bone changes and accurate localization of parathyroid pathology. This review explores the pathophysiology of bone disease in hyper- and hypoparathyroidism and highlights the role of key PET radiotracers: fluorine-18 sodium fluoride ([18F]NaF), fluorine-18 fluorodeoxyglucose ([18F]FDG), fluorine-18 fluorocholine ([18F]FCH), gallium-68 prostate-specific membrane antigen ([68Ga]PSMA). Distinct imaging patterns, such as the [18F]NaF “superscan” in secondary hyperparathyroidism and focal uptake in brown tumors, are discussed alongside tracer-specific strengths. Clinical applications including diagnosis, monitoring response to therapy, and prognostication are examined. We also consider emerging technologies such as artificial intelligence (AI)-assisted interpretation and positron emission tomography/magnetic resonance imaging (PET/MRI) fusion imaging. As PET/CT becomes more accessible, it is likely to play an increasingly central role in the early detection and personalized management of parathyroid-related bone disease.Keywords
This publication has 68 references indexed in Scilit:
- 18F-fluorocholine PET/CT imaging in primary hyperparathyroidism after negative or inconclusive cervical ultrasonography and 99mTc-MIBI scintigraphyJapanese Journal of Radiology, 2024
- F18-Choline PET/CT or MIBI SPECT/CT in the Surgical Management of Primary HyperparathyroidismJAMA Otolaryngology–Head & Neck Surgery, 2024
- 68Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidismEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- The EANM practice guidelines for parathyroid imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology PracticeEndocrine Pathology, 2020
- Preclinical evaluation of [11C]L‐235 as a radioligand for Positron Emission Tomography cathepsin K imaging in boneJournal of Labelled Compounds and Radiopharmaceuticals, 2020
- Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profileEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- 18F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: A prospective, randomized, controlled clinical studyJournal of Bone and Mineral Research, 2013